Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 701–800 of 1,000
Wnt signaling and phosphorylation status of β-catenin: importance of the correct antibody tools
van Noort, M., Weerkamp, F., Clevers, H. C., & Staal, F. J. T. (2007) · Blood · doi:10.1182/blood-2007-05-092445 · Cited by 30
Role of the Wnt/β-catenin network in regulating hematopoiesis
Wilusz, M., & Majka, M. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0029-y · Cited by 33
Heidel, F. H., Arreba-Tutusaus, P., Armstrong, S. A., & Fischer, T. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1436 · Cited by 30
“AML–LSCs are driven by genetic and epigenomic changes, and these alterations influence prognosis and clonal selection.”
InfluentialVirotherapy as An Approach Against Cancer Stem Cells
Ribacka, C., & Hemminki, A. (2008) · Current Gene Therapy · doi:10.2174/156652308784049372 · Cited by 36
“It has been suggested that chronic myelogenous leukemia (CML) blast crisis, a feared escalation of disease progression, may be caused by hematopoietic progenitor cells that attained self-renewal ability by alterations in the Wnt signaling pathway [23].”
BackgroundChronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues
Goldman, J. M., Green, A. R., Holyoake, T. L., Jamieson, C. H. M., Mesa, R. A., Mughal, T. I., Pellicanò, F., Perrotti, D., Skoda, R. C., & Vannucchi, A. M. (2009) · Leukemia · doi:10.1038/leu.2009.142 · Cited by 30
Scaffidi, P., & Misteli, T. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.007 · Cited by 36
Abe, A., Minami, Y., Hayakawa, F., Kitamura, K., Nomura, Y., Murata, M., Katsumi, A., Kiyoi, H., Jamieson, C. H. M., Wang, J. Y. J., et al. (2008) · International Journal of Hematology · doi:10.1007/s12185-008-0221-1 · Cited by 29
“Flow-cytometric analysis and cell sorting were performed as previously published [12, 19].”
Ricci, L. B., Scala, S., Milani, R., Migliavacca, M., Rovelli, A., Bernardo, M. E., Ciceri, F., Aiuti, A., & Biasco, L. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23148 · Cited by 30
Avilés‐Vázquez, S., Chávez‐González, A., Hidalgo‐Miranda, A., Moreno-Lorenzana, D., Arriaga‐Pizano, L., Sandoval-Esquivel, M. A., Ayala‐Sánchez, M., Aguilar, R. J., Alfaro-Ruíz, L. A., & Mayani, H. (2017) · Cancer Medicine · doi:10.1002/cam4.1187 · Cited by 30
“Interestingly, and supporting this idea, Jamieson and colleagues have presented evidence indicating that in blast crisis CML, granulocyte- macrophage progenitors may be the actual LSCs [32].”
BackgroundRegulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche
Schreck, C., Bock, F., Grziwok, S., Oostendorp, R. A. J., & Istvánffy, R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12384 · Cited by 38
Cell Purification: A New Challenge for Biobanks
Almeida, M. I., García‐Montero, A. C., & Órfão, A. (2014) · Pathobiology · doi:10.1159/000358306 · Cited by 29
Stem cells, a two-edged sword: Risks and potentials of regenerative medicine
Piscaglia, A. C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4273 · Cited by 37
Signal Transduction in the Chronic Leukemias: Implications for Targeted Therapies
Ahmed, W. B., & Etten, R. A. V. (2013) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0150-1 · Cited by 44
Effect of Radiofrequency Radiation on Human Hematopoietic Stem Cells
Glaser, K. M., Rohland, M., Kleine‐Ostmann, T., Schräder, T., Stopper, H., & Hintzsche, H. (2016) · Radiation Research · doi:10.1667/rr14405.1 · Cited by 29
“Genotoxic effects, for example, can lead to formation of malignant diseases such as different types of blood cancers (24, 25).”
BackgroundClarke, M. F., & Hass, A. T. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300130 · Cited by 31
In vivo molecular imaging of cancer stem cells.
Heryanto, Y. D., Achmad, A., Taketomi-Takahashi, A., & Tsushima, Y. (2015) · Europe PMC (PubMed Central) · Cited by 33
Nanomaterials for targeted drug delivery to cancer stem cells
Orza, A. I., Casciano, D. A., & Biris, A. S. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.900566 · Cited by 30
“Among these, Tarceva, Sprycel, and Gleevec are high-profile drugs; however, kinase inhibitors are generally highly toxic (Cozzio et al., 2003; Jamieson et al., 2004).”
BackgroundIto, D., Endicott, M. M., Jubala, C. M., Helm, K. M., Burnett, R. C., Husbands, B. D., Borgatti, A., Henson, M. S., Burgess, K. E., Bell, J. S., et al. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.0756.x · Cited by 28
Cancer Stem Cells in Hematopoietic Malignancies
Jones, R. J., & Armstrong, S. A. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.10.012 · Cited by 29
“However, recent data suggest that the leukemia stem cell maintaining blast crisis is more consistent with committed hematopoietic progenitors [6].”
BackgroundDaley, G. Q. (2004) · Cell · doi:10.1016/j.cell.2004.10.015 · Cited by 27
Theocharides, A. P. A., Dobson, S. M., Laurenti, E., Notta, F., Voisin, V., Cheng, P.-Y., Yuan, J. S., Guidos, C. J., Minden, M. D., Mullighan, C. G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.150 · Cited by 27
Nakahara, F., Kitaura, J., Uchida, T., Nishida, C., Togami, K., Inoue, D., Matsukawa, T., Kagiyama, Y., Enomoto, Y., Kawabata, K. C., et al. (2014) · Blood · doi:10.1182/blood-2013-01-476747 · Cited by 26
“The differentiation block by additional genetic events in progenitor stages of CML cells is responsible for the transition fromCML inCP (CML-CP) toCML inBC (CML-BC).(1)CML-CPhas become relatively easy to control with the development of BCRABL inhibitors such as imatinib.”
BackgroundNayak, R. C., Hegde, S., Althoff, M. J., Wellendorf, A. M., Mohmoud, F., Perentesis, J. P., Reina‐Campos, M., Reynaud, D., Zheng, Y., Díaz-Meco, M. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07846-y · Cited by 30
Cells of Origin for Prostate Cancer
Xin, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_4 · Cited by 32
Gu, Y., Hu, X., Liu, X., Cheng, C., Chen, K., Wu, Y., & Wu, Z. (2021) · BMC Cancer · doi:10.1186/s12885-021-08344-z · Cited by 27
YBX1 expression and function in early hematopoiesis and leukemic cells
Bhullar, J., & Sollars, V. E. (2011) · Immunogenetics · doi:10.1007/s00251-011-0517-9 · Cited by 28
“It is maintained by a proper balance between self renewal and multipotent differentiation of the hematopoietic stem cells (HSC) ( Huntley and Gilliland 2005 ).”
BackgroundThe blast phase of chronic myeloid leukaemia
Silver, R. T. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.07.006 · Cited by 27
The Elusive Chronic Myeloid Leukemia Stem Cell: Does It Matter and How Do We Eliminate It?
Carter, B. Z., Mak, D. H. F., Cortes, J. E., & Andreeff, M. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.06.006 · Cited by 30
C/EBPβ promotes BCR–ABL-mediated myeloid expansion and leukemic stem cell exhaustion
Hayashi, Y., Hirai, H., Kamio, N., Yao, H., Yoshioka, S., Miura, Y., Ashihara, E., Fujiyama, Y., Tenen, D. G., & Maekawa, T. (2012) · Leukemia · doi:10.1038/leu.2012.258 · Cited by 29
The impact of gene profiling in chronic myeloid leukaemia
Yong, A. S. M., & Melo, J. V. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.04.002 · Cited by 27
Targeting self-renewal pathways in myeloid malignancies
Sands, W. A., Copland, M., & Wheadon, H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-33 · Cited by 33
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
Basilico, S., & Göttgens, B. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1535-3 · Cited by 31
Identification of a leukemia-initiating stem cell in human mast cell leukemia
Eisenwort, G., Sadovnik, I., Schwaab, J., Jawhar, M., Keller, A., Stefanzl, G., Berger, D., Blatt, K., Hoermann, G., Bilban, M., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0460-6 · Cited by 27
Declaration of Bcr-Abl1 independence
Zhao, H., & Deininger, M. W. (2020) · Leukemia · doi:10.1038/s41375-020-01037-9 · Cited by 30
Hematological malignancies: disease pathophysiology of leukemic stem cells.
Ramdass, B., Chowdhary, A. S., & Koka, P. S. (2013) · PubMed · Cited by 32
Primo, D., Flores-Montero, J. A., Quijano, S., Sánchez, M. L., Sarasquete, M. E., del Pino‐Montes, J., Gaarder, P. I., González, M., & Órfão, A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06265.x · Cited by 30
“…et al, 1998; Holyoake et al, 1999; Kramer et al, 2001; Drummond et al, 2005) and in in vitro (Eaves et al, 1986) studies, without affecting cell death, differentiation and self-renewal capacity in either murine or human models (Huntly et al, 2004; Jamieson et al, 2004a; Jamieson et al, 2004b).”
Backgroundp16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice
Calvo, J. A., Draheim, K., Bhasin, M., & Kelliher, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209326 · Cited by 35
“…Wnt1, Wnt3A and Wnt4 have all been shown required for double negative (DN) and immature single positive (ISP) thymocyte proliferation and survival (Staal and Clevers, 2005), and Wnt activation has also been associated with blast crisis chronic myelogenous leukemia patients (Jamieson et al., 2004).”
BackgroundMeasurable residual disease (MRD)-testing in haematological and solid cancers
Chen, J., Gale, R. P., Hu, Y., Wen, Y., Wang, T., & Zhang, W. (2024) · Leukemia · doi:10.1038/s41375-024-02252-4 · Cited by 35
“Moreover, residual leukaemia cells can be in different immune-phenotype-de fi ned sub-populations with considerable variation among people [146, 147].”
BackgroundShah, M., & Bhatia, R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-97746-1_6 · Cited by 26
Kim, Y. S., Gong, X., Rubin, L. P., Choi, S., & Kim, Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.010 · Cited by 27
γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia
Gardiol, N., Siddiqui, I., Pizzitola, I., Jeevan-Raj, B. P., Charmoy, M., Huang, Y., Irmisch, A., Curtet, S., Angelov, G. S., Danilo, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.005 · Cited by 29
Krishnan, V., Kim, D. D. H., Hughes, T. P., Branford, S., & Ong, S. T. (2021) · Haematologica · doi:10.3324/haematol.2021.279317 · Cited by 32
“Independently, Zheng et al isolated CD34+ cells and identified 34 DEGs as cells transited from CP to 10 BC.”
BackgroundInfluentialPotential role of Marine Bioactive Compounds in cancer signaling pathways: A review
Manoharan, S., & Perumal, E. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175330 · Cited by 29
Fung, T. K., Gandillet, A., & So, C. W. E. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283545615 · Cited by 27
“Jamieson CH, Ailles LE, Dylla SJ, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.”
BackgroundInfluentialWhy Doesn't Imatinib Cure Chronic Myeloid Leukemia?
Redner, R. L. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0297 · Cited by 26
Chung, R., Peters, A., Armanious, H., Anand, M., Gélébart, P., & Lai, R. L. (2010) · PubMed · Cited by 29
A nano-based thermotherapy for cancer stem cell-targeted therapy
Suo, X., Zhang, J., Zhang, Y., Liang, X., Zhang, J., & Liu, D. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00311e · Cited by 28
Somatic mutations and the hierarchy of hematopoiesis
Traulsen, A., Pacheco, J. M., Luzzatto, L., & Dingli, D. (2010) · BioEssays · doi:10.1002/bies.201000025 · Cited by 27
“CFU-GM) acquires stem cell line properties due to the acquisition of specific mutations [51–53].”
BackgroundCofré, J., Menezes, J. R. L., Pizzatti, L., & Abdelhay, E. S. F. W. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-28 · Cited by 27
Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303066 · Cited by 28
Signaling pathways governing the behaviors of leukemia stem cells
Azizidoost, S., Nasrolahi, A., Sheykhi-Sabzehpoush, M., Anbiyaiee, A., Khoshnam, S. E., Farzaneh, M., & Shahab Uddin, M. S. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.008 · Cited by 31
Near-infrared photoimmunotherapy and anti-cancer immunity
Nakajima, K., & Ogawa, M. (2023) · International Immunology · doi:10.1093/intimm/dxad042 · Cited by 28
Upregulation of stem cell genes in multidrug resistant K562 leukemia cells
Lehne, G., Grasmo-Wendler, U.-H., Berner, J., Meza‐Zepeda, L. A., Adamsen, B. L., Flack, A., Reiner, A. H., Clausen, O. P. F., Hovig, E. J., & Myklebost, O. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.03.028 · Cited by 25
The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis
Swanson, M., Kokot, N., & Sinha, U. K. (2016) · Cancers · doi:10.3390/cancers8020024 · Cited by 32
“Just as in hematologic, CNS, and other epithelial malignancies, HNSCC tumor cell behavior can be predicted based on cell surface markers [39–46].”
BackgroundLau, B. W., Huh, K., Madero‐Marroquin, R., Marchi, F. D., Lim, Y., Wang, Q., Lobo, F. P., Marchionni, L., Smith, D. B., Dezern, A. E., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0431-9 · Cited by 28
Cross, N. C. P., Daley, G. Q., Green, A. R., Hughes, T. P., Jamieson, C. H. M., Manley, P. W., Mughal, T. I., Perrotti, D., Radich, J. P., Skoda, R. C., et al. (2008) · Leukemia · doi:10.1038/leu.2008.231 · Cited by 26
Therapeutic Implications of Leukemia Stem Cell Development
Stubbs, M. C., & Armstrong, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3090 · Cited by 26
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?
Tariq, I. (2006) · Frontiers in bioscience · doi:10.2741/1791 · Cited by 29
Lin, E. H., Jiang, Y., Deng, Y., Lapsiwala, R., Lin, T., & Blau, C. A. (2008) · PubMed · Cited by 29
Cancer: Inappropriate Expression of Stem Cell Programs?
Wang, J. Y., & Armstrong, S. A. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.03.014 · Cited by 29
Diverging fates of cells of origin in acute and chronic leukaemia
Kovačic, B., Hoelbl‐Kovacic, A., Litos, G., Alacakaptan, M., Schuster, C., Fischhuber, K., Kerenyi, M. A., Stengl, G., Moriggl, R., Sexl, V., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100208 · Cited by 27
“…from cells that resemble adult tissue stem cells (Huntly et al, 2004; Passegue et al, 2004), over progenitor-like (Cozzio et al, 2003; Jamieson et al, 2004; Kelly et al, 2007; Krivtsov et al, 2006; Somervaille & Cleary, 2006), to mature cells with rearranged B-cell receptors (Barabe…”
The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells
Tian, B., Du, X., Zheng, S., & Zhang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416155 · Cited by 24
“Previous studies have even suggested that mature leukemic progenitor cells or cells expressing lineage markers can initialize tumorigenesis [46,47].”
Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells
Baghdadi, T. A., Abonour, R., & Boswell, H. S. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.10.003 · Cited by 27
LEF‐1 Is a Decisive Transcription Factor in Neutrophil Granulopoiesis
Skokowa, J., & Welte, K. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1392.012 · Cited by 31
Human skin cancer stem cells: a tale of mice and men
Colmont, C. S., Harding, K. G., Piguet, V., & Patel, G. K. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01533.x · Cited by 28
Wang, F., Liang, Y.-J., Wu, X.-P., Chen, L., To, K. K. W., Dai, C.-L., Yan, Y., Wang, Y.-S., Tong, X.-Z., & Fu, L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.032 · Cited by 27
Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis
Gu, Y., Zheng, W., Zhang, J., Gan, X., Ma, X., Meng, Z., Chen, T., Lu, X., Wu, Z., Huang, W., et al. (2016) · Leukemia · doi:10.1038/leu.2016.53 · Cited by 25
“Previous studies have shown that CML progression from a chronic phase to a deadly blast crisis is supported by self-renewing leukemic stem cells (LSCs) (13-22), but the critical drivers triggering blast crisis of CML remain elusive.”
BackgroundLiu, Z., Li, Y., Lv, C., Wang, L., & Song, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.047 · Cited by 25
Kometani, K., Aoki, M., Kawamata, S., Shinozuka, Y., Era, T., Taniwaki, M., Hattori, M., & Minato, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1346 · Cited by 25
Jing, D., Kehoe, D. E., & Tzanakakis, E. S. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0398 · Cited by 26
The Challenges of Targeting Chronic Myeloid Leukemia Stem Cells
Jiang, X., Smith, C. A., Eaves, A. C., & Eaves, C. J. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.s.005 · Cited by 24
The canonical Wnt/β-catenin pathway: From the history of its discovery to clinical application
Grebennikova, T. A., Belaya, Z. E., Rozhinskaya, L. Y., & Mel'nichenko, G. A. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh201688674-81 · Cited by 27
Comprehensive Review on the Effect of Stem Cells in Cancer Progression
Das, S., Khan, T. H., & Sarkar, D. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00053-6 · Cited by 26
“Multiple lines of data suggest that mutated progenitor cells can give rise to the development of cancer stem cells [18–21].”
Zhang, J., Xiao, Y., Guo, Y., Breslin, P., Zhang, S., Wei, W., Zhang, Z., & Zhang, J. (2011) · Leukemia · doi:10.1038/leu.2011.220 · Cited by 24
Wahl, J., Bogatyreva, L., Boukamp, P., Rojewski, M., van Valen, F., Fiedler, J., Hipp, N., Debatin, K., & Beltinger, C. P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25163 · Cited by 27
Antigens in chronic myeloid leukemia: implications for vaccine development
Šmahel, M. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1126-z · Cited by 26
“In BC, another type of LSCs has been identified—granulocyte–macrophage progenitors responsible for rapid expansion of immature blast cells [4].”
BackgroundNew hope in the horizon: cancer stems cells
Bhattacharyya, S., & Khanduja, K. L. (2010) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq013 · Cited by 25
Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia.
Ghasemi, A., Rostami, S., Chahardouli, B., Ghandforoush, N. A., Ghotaslou, A., & Nadali, F. (2015) · PubMed Central · Cited by 23
A novel Bcr-Abl–mTOR–eIF4A axis regulates IRES-mediated translation of LEF-1
Tsai, B. P., Jimenez, J., Lim, S., Fitzgerald, K. D., Zhang, M., Chuah, C. T. H., Axelrod, H. D., Nelson, L. J., Ong, S. T., Semler, B. L., et al. (2014) · Open Biology · doi:10.1098/rsob.140180 · Cited by 26
“We and others have shown that LEF1 is a direct Wnt target gene, suggesting that the increase in LEF1 mRNA at this stage may be due to direct transcriptional activation by an aberrant level of Wnt signalling [7,8,10–12].”
BackgroundInfluentialPost-transcriptional regulation in hematopoiesis: RNA binding proteins take control
de Rooij, L. P. M. H., Chan, D. C. H., Chahi, A. K., & Hope, K. J. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0310 · Cited by 36
Hu, M. S., Xu, C., Yang, C., Zuo, H., Chen, C., Zhang, D., Shi, G., Wang, W., Shi, J., & Zhang, T. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1062-x · Cited by 23
Chronic myelogenous leukemia stem cells: What’s new?
Copland, M. (2009) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-009-0010-9 · Cited by 24
“Further studies by Jamieson et al. [ 9 ] have indicated that the acquisition of selfrenewal capacity in the granulocyte-macrophage progenitor (GMP) cell subpopulation via activation of β-catenin may be responsible for transformation from chronic or acceleratedphase CML to myeloid blast crisis (Fig. 1).”
BackgroundInfluentialCancer stem cells and the cellular hierarchy in haematological malignancies
Johnsen, H. E., Kjeldsen, M. K., Urup, T. H., Fogd, K., Pilgaard, L., Boegsted, M., Nyegaard, M., Christiansen, I., Bukh, A., & Dybkær, K. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70033-4 · Cited by 29
Targeting the Wnt Pathway in Cancer
Goss, K. H., & Kahn, M. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8023-6 · Cited by 24
Systems biology and cancer stem cells
Price, N. D., Foltz, G., Madan, A., Hood, L., & Tian, Q. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00151.x · Cited by 27
“Using mouse genetics and clinical studies, Weissman and colleagues demonstrated that both mechanisms exist in leukemia: while chronic myeloid leukemia can be derived from LSC residing at the HSC stage [55], the more differentiated progenitor—granulocyte-macrophage progenitor (GMP)—can also gain LSC property during the…”
BackgroundBelar, C. D. (2003) · Wiley eBooks · doi:10.1002/0470013389.ch2 · Cited by 23
Allegra, A., Mirabile, G., Caserta, S., Stagno, F., Russo, S., Pioggia, G., & Gangemi, S. (2024) · Antioxidants · doi:10.3390/antiox13040461 · Cited by 28
“Even in patients who have remis-Antioxidants sion, primitive leukemia CD34+ stem/progenitor cells are still present, indicating that TKI therapy is not enough to cure CML [5,6].”
BackgroundNagao, R., Ashihara, E., Kimura, S. H., Strovel, J. W., Yao, H., Takeuchi, M., Tanaka, R., Hayashi, Y., Hirai, H., Padia, J. K., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.002 · Cited by 23
The invasion of de-differentiating cancer cells into hierarchical tissues
Zhou, D., Luo, Y., Dingli, D., & Traulsen, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007167 · Cited by 26
Ito, K., & Ito, K. (2021) · Cancers · doi:10.3390/cancers13225822 · Cited by 27
Filipek-Gorzała, J., Kwiecińska, P., Szade, A., & Szade, K. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1308709 · Cited by 27
“Furthermore, Jamieson et al. reported that during blast phase Lin − CD34 + CD38 + granulocyte-macrophage progenitors (GMPs), which present high levels of BCR-ABL1 and nuclear b -catenin, may turn into leukemic stem cells with self-renewal capacity (173).”
BackgroundKorbecki, J., Bosiacki, M., Szatkowska, I., Kupnicka, P., Chlubek, D., & Baranowska‐Bosiacka, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084365 · Cited by 24
Sun, R., Zhang, J., Xiong, M., Wei, H., Tan, K., Yin, L., & Pu, Y. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120809298 · Cited by 23
“reported the aberrant activation of Wnt/β-catenin pathway may result in enhanced self-renewal capability in GM progenitors in CML [38].”
BackgroundBlockade of JAK2 activity suppressed accumulation of β‐catenin in leukemic cells
Liu, Y., Lai, W., Chuang, K., Shen, Y., Hu, W. S., Ho, C., Chen, Y., Hsu, M., Hsu, H., & Lieu, C. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22714 · Cited by 23
“During a blast crisis of chronic myelogenous leukemia (CML), Wnt/b-catenin signaling is activated resulting in increased expression of BCR-ABL [Jamieson et al., 2004].”
BackgroundMaintenance of Genomic Stability in Mouse Embryonic Stem Cells: Relevance in Aging and Disease
Giachino, C., Orlando, L., & Turinetto, V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022617 · Cited by 27
Miscreant myeloproliferative disorder stem cells
Jamieson, C. H. M., Barroga, C. F., & Vainchenker, W. (2008) · Leukemia · doi:10.1038/leu.2008.290 · Cited by 23
Yin, L., & Kufe, D. W. (2011) · Genes & Cancer · doi:10.1177/1947601911405044 · Cited by 22
“Dysregulation of β-catenin contributes to the arrest of differentiation associated with CML blast crisis.(6) In that line of reasoning, treatment of KU812 cells with GO-203, but not CP-2, resulted in induction of the myeloid/ monocytic marker CD11b (Fig.”
BackgroundInfluentialMotegi, A., Fujii, S., Zenda, S., Arahira, S., Tahara, M., Hayashi, R., & Akimoto, T. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.019 · Cited by 22
RUNX1 haploinsufficiency results in granulocyte colony-stimulating factor hypersensitivity
Chin, D. W. L., Sakurai, M., Nah, G. S. S., Du, L. Z., Jacob, B., Yokomizo, T., Matsumura, T., Suda, T., Huang, G., Fu, X.-Y., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2015.105 · Cited by 22
Weissman, I. L. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112003 · Cited by 26
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.